Show summary Hide summary
NuScale Power stock has collapsed 75% from its October 2025 peak, yet the nuclear reactor company still awaits its first commercial reactor sale. Despite holding the only NRC-certified small modular reactor design in the United States, investors remain anxious about execution timelines. Will the Romanian partnership with RoPower finally unlock the commercial breakthrough investors have been waiting for?
🔥 Quick Facts
- Stock Collapse: SMR dropped 75% from $57.42 October 2025 high to current $12.68 level.
- First Commercial Deal: RoPower Romania approved NuScale’s VOYGR SMR for Europe’s first SMR plant.
- Analyst Consensus: 17 analysts rate SMR as Buy with $21 median price target, implying 66% upside.
- Regulatory Moat: NuScale holds the only NRC-approved SMR design, giving multi-year head start.
The Nuclear Collapse: From $57 Peak to $12 Trough
In October 2025, NuScale Power stock soared to $57.42, fueled by optimism about AI data center power demand and nuclear energy tailwinds. Just six months later, the stock tanked to an $8.85 low on April 13, 2026 before recovering modestly to $12.68 by May 18. This 85% peak-to-trough drawdown ranks among the steepest declines in the clean energy sector this year. The speed and magnitude shocked investors who had believed the nuclear renaissance narrative was locked in. But the market’s harsh reality check revealed a crucial missing ingredient: no signed commercial reactor purchase agreement.
The canceled Utah Associated Municipal Power Systems deal in 2023 spooked investors, who then watched multiple memorandum of understanding announcements through 2024-2025 fail to convert into binding contracts. Citi slashed its price target from $11.50 to just $9, signaling even constructive analysts had lost faith in near-term execution. Meanwhile, NuScale burned through approximately $44 million in Q1 2026 alone, with quarterly revenues collapsing to $0.6 million from $13.4 million in the prior-year period. The cash burn rate became impossible to ignore.
Walmart set to report Q1 earnings May 21, expects $174B revenue
Tax news May 18: IRS offers settlement for conservation easements, Trump Accounts enrollments near 4 million
Why Execution Risk Matters More Than Nuclear Tailwinds
The paradox haunting SMR investors is that policy fundamentals have never looked better for nuclear energy. The U.S. Department of Energy confirmed loan support for the first 5-10 new reactor projects. The Biden administration tripled its nuclear energy goal. Global markets project the small modular reactor space to grow from $7.5 billion in 2025 to $17.4 billion by 2030. Yet none of this broad industry tailwind has translated into the one thing NuScale actually needs: a customer writing a check for a commercial deployment.
NuScale holds the only design certified by the U.S. Nuclear Regulatory Commission, giving it a 5+ year regulatory head start against competitors still navigating the approval gauntlet. The company’s VOYGR-12 plant can produce up to 924 megawatts of carbon-free electricity. But regulatory approval and market demand are two different things. The company met with 37 different supplier partners in early 2026 and opened a new Houston operations center in April to boost commercial visibility. Framatome, the French nuclear reactor company, expanded its fuel supply partnership with NuScale to cover both U.S. and European projects. These moves signal preparation, not yet results.
The Romanian Deal: First Commercial Nod, Not Signed Contract
RoPower, a Romanian utility, approved moving forward with Europe’s first SMR plant using NuScale’s VOYGR reactors in March 2026. This marked the first time any commercial customer had formally committed to deploying NuScale’s technology at scale. However, analysts stressed the distinction between approval and binding agreement. The Romanian project provided concrete validation that utilities view NuScale’s design as deployable, but no final investment decision or construction timeline has been announced. ENTRA1, a separate customer negotiating with the Tennessee Valley Authority, is discussing potential nuclear projects reaching up to 6 gigawatts in capacity, but also remains in negotiation phase.
| Metric | Value |
| Current Stock Price | $12.68 (as of May 18, 2026) |
| 52-Week Range | $8.85 to $57.42 |
| Market Cap | ~$4.09 billion |
| Q1 2026 Revenue | $0.6 million |
| Q1 2026 Net Loss | ~$44 million |
“NuScale Power Corporation ended Q1 with $1 billion in liquidity, which climbed above $1.2 billion by early May, providing a runway to advance the commercialization.”
— Insider Monkey, May 15, 2026
Analyst Bifurcation: $60 Bull Target vs $9 Bear Case
Wall Street’s split personality on SMR stock reveals deep uncertainty about whether commercial deployment actually lands. Of 17 analysts covering the stock, the consensus is Buy with a $21 median price target, implying 66% upside from $12.68 levels. But the dispersion tells the real story: Canaccord Genuity’s George Gianarikas anchors the bull camp with a $60 target, framing SMR as a pure option bet on U.S. small modular reactor commercialization. Citi’s recent cut to $9 from $11.50 represents the cautious bear view. The $51-gap between Street-high and Street-low targets reflects genuine disagreement about whether the company’s regulatory moat converts to revenue or burns out. Most covering analysts cluster around $21, balancing the regulatory advantage against continued execution risk.
The bull case centers on asymmetric upside if RoPower Romania becomes a template. A single signed 924-megawatt VOYGR plant represents roughly $5-8 billion of project value over 60 years, of which NuScale captures meaningful licensing and module-supply revenue. If two such commercial deals close by 2027, fair value pushes well above $21. The bear case emphasizes that cash burn at a pre-revenue company creates dilution risk if commercial sales fail to land in 2026-2027. With only $1.2 billion in liquidity and negative P/E of -5.31, shareholder dilution becomes inevitable if the company must fund another year of $150-200 million in annual cash burn without signing contracts.
Can SMR Stock Recover Without an Immediate Commercial Deal?
Recovery dynamics hinge on catalyst timing. Q1 2026 earnings in May 2026 and DOE loan announcements will be critical rerating moments. Any formal binding commercial reactor purchase agreement would re-rate the stock toward $25-35 within weeks. But if execution continues to slip and the company must burn another $50-100 million in cash through the end of 2026 without a signed deal, downside re-testing of $9 becomes plausible. The honest assessment is that SMR is a binary trade, not a core holding. Risk-tolerant investors might accumulate small positions between $11-13, sizing them as venture-style bets rather than core allocations. Conservative portfolios should wait for a binding commercial agreement before entering.
The underlying technology remains sound, and the nuclear energy market tailwinds intensifying globally cannot be dismissed. Whether NuScale succeeds ultimately depends on executing one critical transaction: converting the Romanian interest and TVA negotiations into signed contracts. Without that catalyst, even the best-in-class regulatory moat cannot justify current valuations for much longer.
Sources
- MEXC Finance Blog – Detailed SMR stock breakdown with analyst consensus tracking and price target analysis, April 28, 2026.
- Yahoo Finance – NuScale Power financial results and institutional analyst ratings covering Q1 2026 earnings, May 15-18, 2026.
- Simply Wall St – RoPower Romania commercial deployment approval and NuScale strategic partnership news, March 12, 2026.
